Pharmacyclics, Inc. (NASDAQ:PCYC)

CAPS Rating: 1 out of 5

A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.

Recs

0
Player Avatar goldminingXpert (99.72) Submitted: 12/11/2009 12:24:22 PM : Underperform Start Price: $2.73 PCYC Score: -1,082.33

Ultralong

Report this Post Reply

Featured Broker Partners


Advertisement